Keyphrases
Hemorrhagic Stroke
80%
Lead (Pb) Exposure
66%
Sciatic Nerve Crush Injury
66%
Intracerebral Transplantation
66%
Bone Marrow Mononuclear Cells
66%
Immunoglobulin G
66%
Human Mesenchymal Stem Cells (hMSCs)
66%
Thymoquinone
66%
Stroke Patients
56%
Stem Cells
55%
Rattus Novergicus
41%
1-year Follow-up
40%
Ginkgo Biloba Extract
38%
Pain Intensity
38%
Acute Stroke
38%
G-levels
37%
Rat Model
37%
Rattus Norvegicus
37%
Statistical Analysis
36%
National Institutes of Health Stroke Scale (NIHSS)
34%
State Patient
33%
Chronic Tension-type Headache
33%
Ommaya Reservoir
33%
Persistent Vegetative State
33%
Dexketoprofen
33%
Primary Headache
33%
Pupillary Response
33%
Olfactory Test
33%
Amnestic Mild Cognitive Impairment (aMCI)
33%
Sleep Quality
33%
APOE Genotype
33%
Sleep Anxiety
33%
Vascular Endothelial Growth Factor
33%
Bdnf
33%
Heat Shock Protein 90 (Hsp90)
33%
Duchenne muscular Dystrophy
33%
Ginkgo Biloba
33%
Infarction
33%
Mathematical Model
33%
Injury Model
33%
Sargassum
33%
Diagnostic Accuracy
33%
Interleukin-6
33%
Number of Neurons
33%
Terpenoids
33%
Score Model
33%
Pain Severity
33%
Active Components
33%
Interleukin-1β
33%
Response Test
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cerebrovascular Accident
83%
Crush Trauma
66%
Nerve Crush
66%
Thymoquinone
66%
Immunoglobulin G
66%
Brain Hemorrhage
66%
Tumor Necrosis Factor
61%
Diseases
48%
Brain Derived Neurotrophic Factor
46%
Ginkgo Biloba Extract
40%
Rat Model
37%
Rattus norvegicus
37%
Toxic Injury
35%
Sargassum
33%
Heat Shock Protein 90
33%
Chronic Tension Headache
33%
Dexketoprofen
33%
Spinal Cord Injury
33%
Vasculotropin
33%
Interleukin 10
33%
Migraine
33%
Terpenoid
33%
Gelatinase B
33%
Infarction
33%
Dystrophin
33%
Duchenne Muscular Dystrophy
33%
Heavy Metal
33%
Ginkgo Biloba
33%
Calcitonin Gene Related Peptide
33%
Case-Control Study
33%
Interleukin 6
33%
Interleukin 1
33%
Factor A
33%
Tumor Necrosis
33%
Lead Poisoning
33%
Persistent Vegetative State
33%
Adverse Event
25%
Neuroprotective Agent
17%
Nuclear Factor
16%
Population Study
15%
Treatment Group
15%
Inflammation
15%
Wistar Rat
10%
Table Salt
9%
Functional Status
8%
Cytoskeleton Protein
8%
Clinical Trial
8%
Mortality Rate
8%
Gene Delivery
8%
Immobility
8%
Medicine and Dentistry
Cerebral Hemorrhage
100%
Bone Marrow Mesenchymal Stem Cell
66%
Apoplexy
62%
Persistent Vegetative State
33%
Ommaya Reservoir
33%
Mild Cognitive Impairment
33%
Pupillary Response
33%
Nutritional Status
33%
Dystrophin
33%
Duchenne Muscular Dystrophy
33%
Diagnostic Accuracy
33%
Brain Derived Neurotrophic Factor
33%
Unified Parkinson's Disease Rating Scale
33%
National Institutes of Health Stroke Scale
32%
Stem Cell
25%
Adverse Event
23%
Diseases
23%
Globus pallidus
22%
Parkinson's Disease
22%
Thalamotomy
22%
Skinfold
19%
Serum Albumin
19%
Computer Assisted Tomography
16%
Gene Expression
16%
Brain Imaging
11%
Thalamus
11%
Magnetic Resonance Imaging
11%
Diagnosis
11%
Disease Severity
11%
Nutritional Status Assessment
9%
Functional Status
8%
Stem Cell Therapy
8%
Cytoskeleton Protein
8%
Gene Transfer
8%
Exon Skipping
8%
Meta-Analysis
8%
Hazard Ratio
8%
Muscle Function
8%
Obesity
8%
Muscle Disease
8%
Life Expectancy
8%
Quality of Life
8%
Muscle Strength
8%
Gene Product
8%
Clinical Trial
8%
Mortality Rate
8%
Short Stature
8%
Virus
8%
Adverse Effect
8%
Hypersensitivity Response
7%
